565 related articles for article (PubMed ID: 32423747)
21. Malignant pleural disease: a pragmatic guide to diagnosis.
Chang CH; Ost DE
Curr Opin Pulm Med; 2022 Jul; 28(4):282-287. PubMed ID: 35749791
[TBL] [Abstract][Full Text] [Related]
22. Useful tests on the pleural fluid in the management of patients with pleural effusions.
Light RW
Curr Opin Pulm Med; 1999 Jul; 5(4):245-9. PubMed ID: 10407695
[TBL] [Abstract][Full Text] [Related]
23. Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.
Froudarakis ME; Plojoux J; Kaspi E; Anevlavis S; Laroumagne S; Karpathiou G; Roca E; Adler D; Dutau H; Astoul P
Clin Respir J; 2018 Mar; 12(3):1011-1016. PubMed ID: 28245530
[TBL] [Abstract][Full Text] [Related]
24. Malignant Pleural Effusion: Presentation, Diagnosis, and Management.
Gayen S
Am J Med; 2022 Oct; 135(10):1188-1192. PubMed ID: 35576996
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review.
Tozzoli R; Basso SM; D'Aurizio F; Metus P; Lumachi F
Clin Biochem; 2016 Nov; 49(16-17):1227-1231. PubMed ID: 27521620
[TBL] [Abstract][Full Text] [Related]
26. [Significance of transthoracic diagnostic interventions in differential diagnosis of exudative pleuritis].
Igonin VA; Dmitrashchenko AA; Akhiev MI
Voen Med Zh; 2009 Apr; 330(4):27-32. PubMed ID: 19537103
[No Abstract] [Full Text] [Related]
27. Pleural fluid procalcitonin to distinguish infectious from noninfectious etiologies of pleural effusions.
Khosla R; Khosla SG; Becker KL; Nylen ES
J Hosp Med; 2016 May; 11(5):363-5. PubMed ID: 26821368
[TBL] [Abstract][Full Text] [Related]
28. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
Wang M; Zhang Z; Wang X
Clinics (Sao Paulo); 2014; 69(12):799-803. PubMed ID: 25627990
[TBL] [Abstract][Full Text] [Related]
29. Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers.
Fazli Khalaf F; Asadi Gharabaghi M; Balibegloo M; Davari H; Afshar S; Jahanbin B
Int J Biol Markers; 2023 Jun; 38(2):81-88. PubMed ID: 36942429
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
[TBL] [Abstract][Full Text] [Related]
31. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
[TBL] [Abstract][Full Text] [Related]
32. Different characteristics of pleural abnormalities on computed tomography between tuberculous and malignant pleural effusions.
Lee J; Park J; Park JE; Lee YH; Choi SH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Lim JK; Kim CH
Am J Med Sci; 2023 Jul; 366(1):57-63. PubMed ID: 37105238
[TBL] [Abstract][Full Text] [Related]
33. Pleural fluid carbohydrate antigen 72-4 and malignant pleural effusion: a diagnostic test accuracy study.
Cao XS; Yan L; Jiang TW; Huang JH; Chen H; Porcel JM; Zheng WQ; Hu ZD
Ther Adv Respir Dis; 2024; 18():17534666231222333. PubMed ID: 38189269
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
[TBL] [Abstract][Full Text] [Related]
35. Role of medical thoracoscopy and closed-blind pleural biopsy in undiagnosed exudative pleural effusions: a single-center experience of 348 patients.
Maturu VN; Dhooria S; Bal A; Singh N; Aggarwal AN; Gupta D; Behera D; Agarwal R
J Bronchology Interv Pulmonol; 2015 Apr; 22(2):121-9. PubMed ID: 25887007
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion.
Basso SMM; Del Conte A; Zuccon U; Sulfaro SC; Fanti G; Maffeis F; Ubiali P; Ermani M; Lumachi F
Anticancer Res; 2020 Oct; 40(10):5877-5881. PubMed ID: 32988918
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
38. Pleural fluid cell-free DNA in parapneumonic pleural effusion.
Santotoribio JD; Cabrera-Alarcón JL; Batalha-Caetano P; Macher HC; Guerrero JM
Clin Biochem; 2015 Oct; 48(15):1003-5. PubMed ID: 26234638
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic principles in pleural disease.
Light RW
Eur Respir J; 1997 Feb; 10(2):476-81. PubMed ID: 9042652
[TBL] [Abstract][Full Text] [Related]
40. Investigation of pleural effusion: comparison between fibreoptic thoracoscopy, needle biopsy and cytology.
Edmondstone WM
Respir Med; 1990 Jan; 84(1):23-6. PubMed ID: 2371417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
